Amines that transport protons across bilayer membranes: Synthesis, lysosomal neutralization, and two-phase pKa values by NMR

Journal of Organic Chemistry

Volumn 61, Issue 14, 1996, Pages 4676-4684

  Dubowchik, Gene M ^a   Padilla, Linda ^a   Edinger, Kurt ^a   Firestone, Raymond A ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001359769     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo960367f     Document Type: Article

References (41)

1. (a) Holtzmann, E. Lysosomes; Plenum Press: New York, 1989.
2. (b) Pisoni, R. L.; Thoene, J. G. Biochim. Biophys. Acta 1991, 1071, 351-373.
3. (c) Mellman, I. J. Exp. Biol. 1992, 172, 39-45.
4. (d) Morton, P. A.; Zacheis, M. L.; Giacoletto, K. S.; Manning, J. A.; Schwartz, B. D. J. Immunol. 1995, 154, 137-150.
5. (a) Seksek, O.; Biwersi, J.; Verkman, A. S. J. Biol. Chem. 1995, 270, 4967-4970.
6. (b) Chidgey, M. A. J. Bioessays 1993, 15, 317-321.
7. (c) Geuze, H. Eur. J. Cell. Biol. 1994, 64, 3-6.
8. Examples of organisms that reside within lysosomes. Bacteria: (a) Maurin, M.; Benoliel, A. M.; Bongrand, P.; Raoult, D. J. Infect. Dis. 1992, 166, 1097-1102. Trypanosomes: (b) Andrews, N. W. Trends Cell. Biol. 1995, 5, 133-137.
9. Examples of organisms that reside within lysosomes. Bacteria: (a) Maurin, M.; Benoliel, A. M.; Bongrand, P.; Raoult, D. J. Infect. Dis. 1992, 166, 1097-1102. Trypanosomes: (b) Andrews, N. W. Trends Cell. Biol. 1995, 5, 133-137.
10. Examples of disease states whose degenerative mechanisms involve lysosomal processing. Alzheimer's disease: (a) Refolo, L. M.; Sambamurti, K.; Efthimiopoulos, S.; Pappolla, M. A.; Robakis, N. K. J. Neurosci. Res, 1995, 40, 694-706. Prion disease: (b) Arnold, J. E.; Tipler, C.; Laszlo, L.; Hope, J.; Landon, M.; Mayer, R. J. J. Pathol. 1995, 176, 403-411. (c) Prusiner, S. B. Sci. Am. 1995, 272, 48-57. Oxidative stress: (d) Ollinger, K.; Brunk, U. T. Free Radical Biol. Med. 1995, 19, 565-574.
11. Examples of disease states whose degenerative mechanisms involve lysosomal processing. Alzheimer's disease: (a) Refolo, L. M.; Sambamurti, K.; Efthimiopoulos, S.; Pappolla, M. A.; Robakis, N. K. J. Neurosci. Res, 1995, 40, 694-706. Prion disease: (b) Arnold, J. E.; Tipler, C.; Laszlo, L.; Hope, J.; Landon, M.; Mayer, R. J. J. Pathol. 1995, 176, 403-411. (c) Prusiner, S. B. Sci. Am. 1995, 272, 48-57. Oxidative stress: (d) Ollinger, K.; Brunk, U. T. Free Radical Biol. Med. 1995, 19, 565-574.
12. Examples of disease states whose degenerative mechanisms involve lysosomal processing. Alzheimer's disease: (a) Refolo, L. M.; Sambamurti, K.; Efthimiopoulos, S.; Pappolla, M. A.; Robakis, N. K. J. Neurosci. Res, 1995, 40, 694-706. Prion disease: (b) Arnold, J. E.; Tipler, C.; Laszlo, L.; Hope, J.; Landon, M.; Mayer, R. J. J. Pathol. 1995, 176, 403-411. (c) Prusiner, S. B. Sci. Am. 1995, 272, 48-57. Oxidative stress: (d) Ollinger, K.; Brunk, U. T. Free Radical Biol. Med. 1995, 19, 565-574.
13. Examples of disease states whose degenerative mechanisms involve lysosomal processing. Alzheimer's disease: (a) Refolo, L. M.; Sambamurti, K.; Efthimiopoulos, S.; Pappolla, M. A.; Robakis, N. K. J. Neurosci. Res, 1995, 40, 694-706. Prion disease: (b) Arnold, J. E.; Tipler, C.; Laszlo, L.; Hope, J.; Landon, M.; Mayer, R. J. J. Pathol. 1995, 176, 403-411. (c) Prusiner, S. B. Sci. Am. 1995, 272, 48-57. Oxidative stress: (d) Ollinger, K.; Brunk, U. T. Free Radical Biol. Med. 1995, 19, 565-574.
14. (a) Dubowchik, G. M.; Padilla, L. M.; Edinger, K.; Firestone, R. A. Biochim. Biophys. Acta 1994, 1191, 103-108.
15. (b) Marquardt, D.; Center, M. S. Cancer Res. 1992, 52, 3157-3163.
16. (c) Simon, S.; Roy, D.; Schindler, M. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 1128-1132.
17. (d) Boiocchi, M.; Toffoli, G. Eur. J. Cancer 1992, 28A, 1099-1105.
18. (e) Slapak, C. A.; Lecerf, J. M.; Daniel, J. C.; Levy, S. B. J. Biol. Chem. 1992, 267, 10638-10644.
19. (a) Bullough, P. A.; Hughson, F. M.; Skehel, J. J.; Wiley, D. C. Nature 1994, 371, 37-43.
20. (b) Gaudin, Y.; Ruigrok, R. W. H.; Brunner, J. J. Gen. Virol. 1995, 76, 1541-1556.
21. Miller, D. K.; Griffiths, E.; Lenard, J.; Firestone, R. A. J. Cell Biol. 1983, 97, 1841-1851.
22. (b) Firestone, R. A.; Pisano, J. M.; Bonney, R. J. J. Med. Chem. 1979, 22, 1130-1133.
23. 6): Holmes, D. L.; Lightner, D. A. Tetrahedron 1995, 51, 1607-1622.
24. Bönneman, H.; Brinkmann, S.; Schenkluhn, H. Synthesis 1974, 575-577.
25. Lipschutz, B. H.; Huff, B.; Hagen, W. Tetrahedron Lett. 1988, 29, 3411-3414.
26. Erni, B.; Khorana, H. G. J. Am. Chem. Soc. 1980, 102, 3888-3896.
27. Middleton, W. J; Bingham, E. M. J. Org. Chem. 1980, 45, 2883-2887.
28. a could not be measured using our method was N-(adamantylmethyl)adamantylamine (20), the protonated form of which was insoluble in both the aqueous and organic phases.
29. Perrin, D. D. Dissociation Constants of Organic Bases in Aqueous Solution: Supplement 1972; Butterworths: London, 1972.
30. Reichardt, C Solvents and Solvent Effects in Organic Chemistry; VCH: New York, 1988.
31. a measurement in nonaqueous solvents, see: Bordwell, F. G. Acc. Chem. Res. 1988, 21, 456-463 and refernces therein.
32. Casey, R. P.; Hollemans, M.; Tager, J. M. Biochim. Biophys. Acta 1978, 508, 15-26.
33. Datta, D. B. A Comprehensive Introduction to Membrane Biochemistry; Floral Publishing: Madison, 1987.
34. Recent examples: (a) Lambert, E; Breinlinger, E. C.; Rotello, V. M. J. Org. Chem. 1995, 60, 2646-2647. (b) Miyake, H.; Yamashita, T.; Kojima, Y.; Tsukube, H. Tetrahedron Lett. 1995, 36, 7669-7672. (c) Colton, I. J.; Kazlauska, R. J. J. Org. Chem. 1994, 59, 3626-3635.
35. Recent examples: (a) Lambert, E; Breinlinger, E. C.; Rotello, V. M. J. Org. Chem. 1995, 60, 2646-2647. (b) Miyake, H.; Yamashita, T.; Kojima, Y.; Tsukube, H. Tetrahedron Lett. 1995, 36, 7669-7672. (c) Colton, I. J.; Kazlauska, R. J. J. Org. Chem. 1994, 59, 3626-3635.
36. Recent examples: (a) Lambert, E; Breinlinger, E. C.; Rotello, V. M. J. Org. Chem. 1995, 60, 2646-2647. (b) Miyake, H.; Yamashita, T.; Kojima, Y.; Tsukube, H. Tetrahedron Lett. 1995, 36, 7669-7672. (c) Colton, I. J.; Kazlauska, R. J. J. Org. Chem. 1994, 59, 3626-3635.
37. (a) Behr, J.-P.; Lehn, J.-M. J. Am. Chem. Soc. 1973, 95, 6108-6110.
38. (b) Lehn, J.-M. In Physical Chemistry of Transmembrane Ion Motions; Elsevier: Amsterdam, 1983.
39. Ohkuma, S; Poole, B. Proc. Natl. Acad. Sci. U.S.A. 1978, 75, 3327-3331
40. Poole, B; Ohkuma, S. J. Cell Biol. 1981, 90, 665-669.
41. Cabral Marques, H. M.; Hadgraft, J.; Kellaway, I. W.; Pugh, W. J. Int. J. Pharm. 1990, 63, 267-274.